https://refrain.ing/en 2026-03-16T07:04:07.958Z weekly 1 https://refrain.ing/sv 2026-03-16T07:04:07.958Z weekly 1 https://refrain.ing/en/about 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/sv/about 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/en/pricing 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/sv/pricing 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/en/faq 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/sv/faq 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/en/contact 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/sv/contact 2026-03-16T07:04:07.958Z weekly 0.8 https://refrain.ing/en/privacy 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/sv/privacy 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/en/terms 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/sv/terms 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/en/news 2026-03-16T07:04:07.959Z daily 0.9 https://refrain.ing/sv/news 2026-03-16T07:04:07.959Z daily 0.9 https://refrain.ing/en/insights 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/sv/insights 2026-03-16T07:04:07.959Z weekly 0.8 https://refrain.ing/en/news/2026-02-25-2026-02-25-ai-chatbots-emerge-harm-reduction-drug 2026-02-25T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-02-25-2026-02-25-ai-chatbots-emerge-harm-reduction-drug 2026-02-25T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-02-26-2026-02-26-ibogaine-therapy-boasts-60-88-success-rates 2026-02-26T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-02-26-2026-02-26-ibogaine-therapy-boasts-60-88-success-rates 2026-02-26T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-02-27-2026-02-27-psychiatrist-launches-mindfiti-platform-addiction-recovery 2026-02-27T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-02-27-2026-02-27-psychiatrist-launches-mindfiti-platform-addiction-recovery 2026-02-27T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-02-28-2026-02-28-ai-therapy-shows-promise-raises-questions 2026-02-28T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-02-28-2026-02-28-ai-therapy-shows-promise-raises-questions 2026-02-28T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-01-2026-03-01-virtual-reality-helps-rewire-brains-response 2026-03-01T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-01-2026-03-01-virtual-reality-helps-rewire-brains-response 2026-03-01T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-02-2026-03-02-trump-administration-launches-major-recovery-initiative 2026-03-02T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-02-2026-03-02-trump-administration-launches-major-recovery-initiative 2026-03-02T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-04-2026-03-04-recovery-strength-redefined-eating-disorder-communities 2026-03-04T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-04-2026-03-04-recovery-strength-redefined-eating-disorder-communities 2026-03-04T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-05-2026-03-05-dangerous-contaminant-street-fentanyl-raises-alarm 2026-03-05T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-05-2026-03-05-dangerous-contaminant-street-fentanyl-raises-alarm 2026-03-05T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-06-2026-03-06-york-considers-ai-chatbot-liability-rules 2026-03-06T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-06-2026-03-06-york-considers-ai-chatbot-liability-rules 2026-03-06T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-07-2026-03-07-science-building-habits-recovery 2026-03-07T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-07-2026-03-07-science-building-habits-recovery 2026-03-07T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-08-2026-03-08-glp-1-medications-show-promise-against-multiple 2026-03-08T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-08-2026-03-08-glp-1-medications-show-promise-against-multiple 2026-03-08T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-09-2026-03-09-ai-therapy-shows-promise-emergency-care 2026-03-09T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-09-2026-03-09-ai-therapy-shows-promise-emergency-care 2026-03-09T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-10-2026-03-10-scotland-pushes-legal-right-addiction-treatment 2026-03-10T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-10-2026-03-10-scotland-pushes-legal-right-addiction-treatment 2026-03-10T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-13-dangerous-discovery-fentanyl-found-vape-pens 2026-03-13T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-13-dangerous-discovery-fentanyl-found-vape-pens 2026-03-13T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-14-breakthrough-diabetes-medications-show-promise-addiction 2026-03-14T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-14-breakthrough-diabetes-medications-show-promise-addiction 2026-03-14T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-15-experts-debunk-viral-fentanyl-myths-contaminated 2026-03-15T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-15-experts-debunk-viral-fentanyl-myths-contaminated 2026-03-15T12:00:00.000Z never 0.6 https://refrain.ing/en/news/2026-03-16-brain-study-shows-opioid-use-changes 2026-03-16T12:00:00.000Z never 0.6 https://refrain.ing/sv/news/2026-03-16-brain-study-shows-opioid-use-changes 2026-03-16T12:00:00.000Z never 0.6 https://refrain.ing/en/insights/2026-02-25-busting-myth-addiction-isnt-permanent-brain 2026-03-16T07:04:07.959Z monthly 0.7 https://refrain.ing/sv/insights/2026-02-25-busting-myth-addiction-isnt-permanent-brain 2026-03-16T07:04:07.959Z monthly 0.7 https://refrain.ing/en/insights/2026-02-27-double-edged-sword-neuroplasticity-creates-heals-addiction 2026-03-16T07:04:07.959Z monthly 0.7 https://refrain.ing/sv/insights/2026-02-27-double-edged-sword-neuroplasticity-creates-heals-addiction 2026-03-16T07:04:07.959Z monthly 0.7